9 companies

Selvita

Market Cap: zł517.6m

Provides drug discovery, drug development, and contract testing services in Poland.

SLV

zł28.60

7D

2.3%

1Y

-10.3%

Bayer

Market Cap: zł47.6b

Operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil.

BAY

zł210.50

7D

0.9%

1Y

74.3%

Genomed Spólka Akcyjna

Market Cap: zł39.6m

Provides DNA and RNA sequencing and analysis and diagnostics services for congenital diseases in Poland.

GEN

zł29.60

7D

-4.5%

1Y

14.7%

Biogened

Market Cap: zł48.1m

Produces and sells cosmetics and toiletries in Poland.

BGD

zł20.00

7D

2.0%

1Y

-18.7%

Novo Nordisk

Market Cap: zł1.3t

Engages in the research and development, manufacture, and distribution of pharmaceutical products.

NVO

zł175.12

7D

3.0%

1Y

-13.5%

Celon Pharma

Market Cap: zł1.2b

An integrated pharmaceutical company, engages in the research, manufacture, and marketing of specialised generic products.

CLN

zł22.20

7D

8.8%

1Y

-3.5%

Krka d. d

Market Cap: zł7.8b

A generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally.

New

KRK

zł1,110.00

7D

-1.6%

1Y

32.5%

Eli Lilly

Market Cap: zł1.1t

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.

LILY

zł4,640.00

7D

3.2%

1Y

n/a

Ryvu Therapeutics

Market Cap: zł434.7m

A clinical-stage drug discovery and development company, engages in developing of small molecule therapies for treatment in oncology in Poland, European Union, and internationally.

RVU

zł18.40

7D

1.0%

1Y

-37.8%